XBI
State Street SPDR S&P Biotech ETF
ETF
$154.43−0.08 (−0.05%)Close Oct 2, 2026
Top holdings
161 in all, as of Jun 30, 2026| Holding | Weight (%) | Value |
|---|---|---|
| State Street Global Advisors | 5.9 | $635M |
| Apogee Therapeutics Inc | 1.5 | $160M |
| MRNAModerna Inc | 1.4 | $152M |
| TWSTTwist Bioscience Corp | 1.4 | $151M |
| ORKAOruka Therapeutics Inc | 1.4 | $148M |
| KYMRKymera Therapeutics Inc | 1.4 | $146M |
| VKTXViking Therapeutics Inc | 1.3 | $140M |
| PRAXPraxis Precision Medicines Inc | 1.3 | $139M |
| ERASErasca Inc | 1.3 | $136M |
| RVMDRevolution Medicines Inc | 1.2 | $129M |
Asset classes
- Stocks
- 99.9%
- Cash and equivalents
- 5.9%
- Derivatives
- 0.1%
- Net other assets
- −5.9%
Stock sectors
- Health Care
- 95.0%
- Consumer Discretionary
- 1.2%
- Information Technology
- 0.2%
- Not classified
- 3.5%
Countries
- United States
- 94.7%
- Ireland
- 1.2%
- Bermuda
- 1.2%
- Netherlands
- 1.0%
- Switzerland
- 1.0%
- British Virgin Islands
- 0.5%
- Canada
- 0.2%